Meadow Creek Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$10.6M Buy
98,028
+21,476
+28% +$2.24M 0.21% 88
2019
Q2
$7.46M Buy
76,552
+26,712
+54% +$2.44M 0.15% 133
2019
Q1
$4.54M Buy
49,840
+17,360
+53% +$1.55M 0.09% 199
2018
Q4
$2.95M Sell
32,480
-7,448
-19% -$696K 0.07% 259
2018
Q3
$3.93M Sell
39,928
-924
-2% -$85.4K 0.08% 237
2018
Q2
$3.5M Buy
40,852
+8,260
+25% +$690K 0.07% 241
2018
Q1
$2.62M Buy
32,592
+420
+1% +$34.6K 0.06% 260
2017
Q4
$2.6M Buy
32,172
+10,668
+50% +$854K 0.06% 276
2017
Q3
$1.67M Sell
21,504
-2,268
-10% -$188K 0.04% 319
2017
Q2
$2.11M Sell
23,772
-392
-2% -$33.1K 0.05% 283
2017
Q1
$1.95M Buy
24,164
+6,664
+38% +$521K 0.05% 300
2016
Q4
$1.25M Buy
+17,500
New +$1.37M 0.03% 339

Other funds holding MDT

Meadow Creek Investment Management's MDT Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Medtronic (MDT) stake by 28% in Q3 2019, buying an estimated $2.24M and bringing the position to 98,028 shares worth $10.6M. The position accounts for 0.21% of the portfolio, ranked #88.

Meadow Creek Investment Management first reported a position in MDT in Q4 2016 and has held it in 12 quarters since. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Meadow Creek Investment Management held 98,028 shares of Medtronic worth $10.6M as of Q3 2019.
  • Meadow Creek Investment Management bought 21,476 Medtronic shares in Q3 2019, an estimated $2.24M.
  • Medtronic made up 0.21% of Meadow Creek Investment Management's portfolio in Q3 2019, its #88 holding.
  • Meadow Creek Investment Management first reported a position in Medtronic in Q4 2016 and has held it in 12 quarters since.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.